MISABRI PR 330 mg prolonged-release tablets

Manufacturer/MA Holder: CNX Therapeutics Ltd
MA Number: PL 19635/0010
Drug Safety Category

3

Active Ingredient

Pregabalin

Formulation

Prolonged Release Tablet

Strength

330mg

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

No

Length/Diameter

19mm

SPC URL

Open SPC